An interventional study of Treadmill Stress test in Myocarditis Acute and Ventricular Arrythmia, sponsored by University Hospital, Angers. Active, not recruiting at 4 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-06.
Sponsored by University Hospital, Angers · Not applicable, Interventional, and Screening
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 31 studies in Myocarditis with a site in France — 11 open to participants now, 13 under way, 2 of them phase 3. Myocarditis · France.
Among the 31 studies in Myocarditis with a site in France, this one is the 9th largest by planned enrollment of the 12 interventional ones that give a count, is one of 3 that started in 2019, is one of 7 with no phase, reaches primary completion later than 6 of the 12 other live ones, and was the 6th registered.
175 studies on the registry are indexed under Myocarditis; 75 are open to participants now.
Browse Myocarditis studies →11 of the 31 studies in Myocarditis with a site in France are open now. Recruiting first, the newest first:
Groupe Hospitalier Pitie-Salpetriere · Sites in France
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18–65
Central Hospital, Nancy, France · Sites in France
Ages 18–80
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 53 Myocarditis studies recruiting now, 32 (60%) set no upper age limit and 6 (11%) stop at 75 or younger; 15 take children under 18; 14 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
31 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 3
First in 2016; this study’s year is marked. 3 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 80 across 53 interventional studies indexed under Myocarditis.
Median enrollment 110 across the 12 interventional studies, 500 across the 19 observational. Of the 15 that completed or were terminated, 1 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 31 have an industry lead sponsor. The 10 most frequent:
University Hospital, Angers is the lead sponsor of 481 studies on the registry; 122 are open to participants now.
University Hospital, Angers has 1 study filed under Myocarditis — fewer than ten, so there is no comparison to draw.
3 of the studies in Myocarditis with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07077304Assistance Publique - Hôpitaux de ParisEACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases | 2027-08-31 |
| NCT07633587Groupe Hospitalier Pitie-SalpetriereATROPOS: Survival Analysis of ICI-associated Myocarditis | 2027-10-01 |
| NCT03842592University Hospital, AngersVentricular Arrhythmia After Myocarditis in Sportsman | 2027-11 |
Add all 3 to your calendar (.ics) → With an account.
Among the 31 studies in Myocarditis with a site in France, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The study aims to assess the prevalence of ventricular rhythmic disorder after an acute myocarditis in sportsmen.
50 patients with acute myocarditis, confirmed by MRI, will be assessed by ECG Holter and Treadmill stress test during a 1-year follow-up.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Stress testing and 24-hour Holter ECG are the tools currently recommended for assessing rhythmic load and, consequently rhythmic risk. These investigations will be perform at 1 years after myocardite.
Diagnostic Test: Treadmill Stress test
Ventricular arrhythmia will be assessed by ECG Holter and during treadmill stress test, both being performed 3 months and 1 year after acute myocarditis
Also known as: ECG Holter
Complex ventricular arrhythmia
any ventricular tachycardia (triplet or more), ventricular fibrillation (observed on ECG Holter or during stress test)
Time frame: any timepoint: 3 month and/or 1 year
In-hospital ventricular arrhythmia
any ventricular tachycardia (triplet or more), ventricular fibrillation, recorded on ECG monitoring
Time frame: up to 2 weeks after admission
Left Ventricular remodeling
Change in LV volumes during time
Time frame: between baseline and 3 months
Left ventricular fibrosis
Change in interstitial fibrosis by T1 mapping cardiac magnetic resonnance
Time frame: between baseline and 3 months
Major adverse cardio vascular event
CV death, sudden cardiac death, cardiac graft or haemodynamic support, hospitalisation for heart failure, new event of myocarditis
Time frame: up to 2 years after inclusion
return to physical activity
defined as at least 75% of exercising time (in hours per week)
Time frame: up to 2 years after inclusion
Plan to share: Undecided
Started Nov 2019 (actual). Primary completion is estimated for Nov 2027, 96 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.